COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 2029: Articles 20281-20290  | Next

Modeling the Effect of Lockdown Timing as a COVID-19 Control Measure in Countries with Differing Social Contacts
Oraby, T., Tyshenko, M. G., Maldonado, J. C., Vatcheva, K., Elsaadany, S., Alali, W. Q., Longenecker, J. C., Al-Zoughool, M.
10.1101/2020.11.14.20231886 — Posted: 2020-11-16
Capability impacts of the Covid-19 lockdown in association with mental well-being, social connections and existing vulnerabilities: an Austrian survey study
Simon, J., Helter, T. M., White, R. G., van der Boor, C., Laszewska, A.
10.1101/2020.11.14.20231142 — Posted: 2020-11-16
Impact of the COVID-19 pandemic on Older Adults Mental Health Services: a mixed methods study
Bhome, R., Huntley, J., Dalton-Locke, C., Vera San Juan, N., Oram, S., Foye, U., Livingston, G.
10.1101/2020.11.14.20231704 — Posted: 2020-11-16
Developing services for long Covid: lessons from a study of wounded healers
Ladds, E., Rushforth, A., Wieringsa, S., Taylor, S., Rayner, C., Husain, L., Greenhalgh, T.
10.1101/2020.11.13.20231555 — Posted: 2020-11-16
Evaluation of the Panbio rapid antigen test for SARS-CoV-2 in primary health care centers and test sites.
Bulilete, O., Lorente, P., Leiva, A., Carandell, E., Oliver, A., Rojo, E., Pericas, P., Llobera, J., COVID-19 Primary Care Research Group
10.1101/2020.11.13.20231316 — Posted: 2020-11-16
Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment
Brook, C. E., Northrup, G. R., Ehrenberg, A. J., The IGI Testing Consortium, T. I. T. C., Doudna, J. A., Boots, M.
10.1101/2020.11.12.20230870 — Posted: 2020-11-16
Role of air temperature and humidity in the transmission of SARS-CoV-2 in the United States
Ma, Y., Pei, S., Shaman, J., Dubrow, R., Chen, K.
10.1101/2020.11.13.20231472 — Posted: 2020-11-16 Discussion: Onsite
Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
Shioda, K., Lau, M. S., Kraay, A. N., Nelson, K. N., Siegler, A. J., Sullivan, P. S., Collins, M. H., Weitz, J. S., Lopman, B. A.
10.1101/2020.11.13.20231266 — Posted: 2020-11-16
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
Shields, A. M., Faustini, S. E., Perez-Toledo, M., Jossi, S., Allen, J. D., Al-Taei, S., Backhouse, C., Dunbar, L., Ebanks, D., Emmanuel, B., Faniyi, A. A., Garvey, M. A., Grinbergs, A., McGinnell, G., O'Neill, J., Watanabe, Y., Crispin, M., Wraith, D. C., Cunningham, A. F., Drayson, M. T., Richter, A. G.
10.1101/2020.11.12.20230763 — Posted: 2020-11-16
Specific immune-regulatory transcriptional signatures reveal sex and age differences in SARS-CoV-2 infected patients
Freire, P. P., Marques, A. H. C., Baiocchi, G. C., Schimke, L. F., Fonseca, D. L. M., Figueiras, I. S., Salgado, R. C., Napoleao, S. M. S., Placa, D. R., Hirata, T. D. C., Khawanky, N. E., Giil, L. M., Miranda, G. C., Carvalho, R. F., Ferreira, L. C. d. S., Condino-Neto, A., Nakaya, H. T. I., Jurisica, I., Ochs, H. D., Camara, N. O. S., Calich, V. L. G., Cabral-Marques, O.
10.1101/2020.11.12.20230417 — Posted: 2020-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).